Article · 13 Feb 2026
Conference abstractPublished 3 Aug 2015
Drug regulations in India- A critical analysis
University of Law, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The regulation of medicines in UK probably began in the fifteenth century to make sure that they were not contaminated or defective. âÂ?Â?Medicinal ProductsâÂ?Â? are defined as âÂ?Â?any substance or combination of substances presented as having properties for treating or preventing disease in human beings.âÂ?Â? Before making any medicine in the market clinical trials are necessary not only in India but in the entire world. A clinical trial is a scientific investigation to evaluate the effect of new drugs or vaccines other than health interventions, by administering these to human volunteers. Generally, clinical trial has three phases before manufacture of drugs. In the beginning of the current century Drug Industry was practically non-existent in India and pharmaceuticals were being imported from abroad. After the First World War manufacturing of drugs started in India. To control the manufacture, distribution and sale of drugs and medicines the Government passed the following two Acts. a) The Poisons Act, 1919; b) Dangerous Drugs Act, 1930. The Government also adopted The Opium Act, 1878. Drugs Act was passed in the year 1940. By passing Narcotic Drugs and Psychotropic substances Act in the year 1985 it repealed all previous Acts. The other Acts which are regulating the manufacture, sale, import, export and clinical research of drugs and cosmetics are as follows: a) The Drugs and Cosmetics Act, 1940; b) The Pharmacy Act, 1948; c) The Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954; d) The Medicinal and Toilet Preparations (Exercise Duties) Act, 1956; e) The Drugs (Prices Control) Order, 1995 (Under the Essential Commodities Act).
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “K V S Sarma”
